Romcef-T 281.25 Injection
Marketer
Biovensia Pharmaceutical
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Romcef-T 281.25 Injection
Cefuroxime Axetil Injection, 281.25 mg, is a dual-action medication used to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire treatment course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) demand prompt medical intervention. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness mandates driving cessation. Adequate rest, balanced nutrition, and sufficient hydration promote faster recovery. Your physician may order laboratory tests to monitor treatment effectiveness.
Uses of Romcef-T 281.25 Injection
Infections caused by bacteria
Major Benefits of Romcef-T 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Romcef-T 281.25 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Romcef-T 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Romcef-T 281.25 Injection works:
Ceftriaxone and Tazobactum, combined as Romcef-T 281.25 Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. Tazobactum, a beta-lactamase inhibitor, complements this by countering bacterial resistance mechanisms, thereby strengthening Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Romcef-T 281.25 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Romcef-T 281.25 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Cefixime injection (Romcef-T 281.25 mg) requires careful consideration when breastfeeding. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Romcef-T 281.25 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Romcef-T 281.25 Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Cefditoren pivoxil injection (281.25 mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for this injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Romcef-T 281.25 Injection :
Omitting a scheduled dose of Romcef-T 281.25 Injection necessitates contacting your physician.
Facts to Know About Romcef-T 281.25 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently